From the outside, a USPTO filing looks straightforward — just translate your domestic documents into English. This misconception creates serious professional liability. US patent practice operates within a dense web of rules: the specification section order prescribed by 37 CFR 1.77, the Information Disclosure Statement (IDS) obligation that runs throughout prosecution, a tiered fee system based on entity status, and the provisional application — a mechanism unique to US law. A lapse in any one of these areas can, at best, generate unnecessary costs and, at worst, render an entire patent unenforceable.

This guide is written for patent practitioners with a background in Chinese, Japanese, or Korean patent practice who are handling — or preparing to handle — US patent applications.

I. The Complete Document Set for a US Non-Provisional Utility Patent Application

A complete US non-provisional utility patent application consists of two categories of documents: administrative filing documents and the specification body.

Administrative Document Checklist

Document	Required / Optional	Notes
Utility Application Transmittal (PTO/AIA/15)	Required	Application transmittal form
Fee Transmittal (PTO/SB/17)	Required	Fee transmittal form
Application Data Sheet (PTO/AIA/14)	Effectively required	Contains inventor information and priority claims
Inventor's Oath or Declaration	Required (may be delayed)	Under AIA, may be deferred until payment of the issue fee
Information Disclosure Statement (IDS)	Legal obligation	Practically mandatory; see Section III
Entity Status Form	Required declaration	Determines fee tier; see Section IV
Nonpublication Request	Optional	Can only be elected at filing; cannot be added later

Specification Body

Under 37 CFR 1.77(b), specification sections must appear in strict sequence, with section headings entirely in uppercase, without bold, italics, or underlining:

No.	Section	Required / Optional
1	TITLE OF THE INVENTION	Required
2	CROSS-REFERENCE TO RELATED APPLICATIONS	Required when related applications exist
3	STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH	Required when federally funded
4	BACKGROUND OF THE INVENTION	Required
5	BRIEF SUMMARY OF THE INVENTION	Required
6	BRIEF DESCRIPTION OF THE DRAWINGS	Required when drawings are included
7	DETAILED DESCRIPTION OF THE INVENTION	Required
8	CLAIMS	Required; must begin on a new page
9	ABSTRACT OF THE DISCLOSURE	Required; must begin on a new page; ≤150 words
10	SEQUENCE LISTING	Required when nucleic acid or amino acid sequences are involved

2024 DOCX Format Requirement

Effective January 17, 2024, the specification, claims, and abstract for non-provisional utility patent applications must be submitted in DOCX format. Failure to comply results in a non-DOCX surcharge:

Large entity: $430
Small entity: $172
Micro entity: $86

Provisional applications and design applications may still be submitted in PDF without surcharge. This is not a recommendation — it is a hard requirement enforced during USPTO formalities review.

II. Claims-First: The Core Methodology of US Patent Drafting

In China and Japan, many practitioners habitually begin with the technical field and background sections of the specification, distilling the claims at the end. US patent practice takes the opposite approach — Claims-First.

The logical foundation of this methodology is that the claims define the legal boundaries of patent protection. By first determining what is to be protected, the specification can then be written to support the claims, preventing the inclusion of large amounts of content irrelevant to the scope of protection while ensuring that every claim has adequate written description support (the written description requirement of 35 U.S.C. 112(a)).

Typical Drafting Workflow

Step 1: Inventor interview + prior art search
Step 2: Draft independent claims (method / system / CRM)
Step 3: Develop dependent claims
Step 4: Draft the specification (Background → Summary → Brief Description → Detailed Description)
Step 5: Draft the abstract (≤150 words)
Step 6: Formal drawings (compliant with 37 CFR 1.84)
Step 7: Complete administrative forms (ADS / Declaration / Entity Status)
Step 8: Prepare IDS (PTO/SB/08)

Fundamental Differences Between US and Chinese Claim Formats

Chinese claims conventionally use a two-part structure — "A [device/method], characterized in that it comprises:". US practice does not use the two-part (Jepson) format as standard; instead, claims use open-ended transitional phrases:

Method claim: A method for [X], comprising: ...
System/apparatus claim: A system for [X], comprising: ...
Computer-readable storage medium: A non-transitory computer-readable medium storing instructions that, when executed by a processor, cause the processor to perform operations comprising: ...

The computer-readable medium (CRM) claim is a standard third independent claim type in US software patents and has no direct counterpart in Chinese or European practice — it must be drafted as a separate independent claim.

Claim Count and Excess Claim Fees

USPTO charges excess claim fees beyond the base quota:

Excess Type	Large Entity / claim	Small Entity / claim	Micro Entity / claim
Total claims exceeding 20	$100	$40	$20
Independent claims exceeding 3	$460	$184	$92

As a result, US practice tends toward more compact claim sets: typically 3 independent claims (method / system / CRM) plus 15–17 dependent claims, staying within the fee thresholds. This contrasts sharply with the large claim sets common in Chinese practice (sometimes exceeding 50 claims).

III. IDS — The "Duty of Candor" in US Patent Law

The IDS (Information Disclosure Statement) is the most distinctive feature of the US patent system and the one most frequently overlooked by non-US practitioners. No directly analogous legal obligation exists in Chinese, Japanese, Korean, or European practice.

Legal Basis and Nature

The IDS derives from the Duty of Candor and Good Faith codified in 37 CFR 1.56: all individuals who are substantively involved in preparing or prosecuting an application — including inventors, agents/attorneys, and other substantive participants — are obligated to disclose to the USPTO all information known to them that is material to patentability.

This duty runs from filing through the grant of the patent and is not discharged simply because the examiner did not ask.

What Must Be Submitted in an IDS

Using Form PTO/SB/08, the applicant must list:

US patent documents: patent number, inventor, publication date
US patent application publications: publication number, inventor, publication date
Foreign patent documents: country/region code, document number, publication date
Non-patent literature (NPL): complete bibliographic information for papers, technical manuals, etc.

Attachment requirements: a copy of each cited reference must be enclosed (except US patents and US patent application publications); non-English documents must be accompanied by an English translation if one exists and is within the applicant's control.

Four Submission Windows (37 CFR 1.97)

IDS requirements become progressively more onerous as prosecution advances:

Window	Time Period	Requirements
Window 1	Within 3 months of filing date, or before the first Office Action (whichever is earlier)	Free; no additional requirements
Window 2	After Window 1, before a final Office Action / Notice of Allowance / Ex parte Quayle action	Must submit a 1.97(e) statement or pay the government fee
Window 3	After Window 2, on or before payment of the issue fee	Must submit a 1.97(e) statement and pay the government fee
Window 4	After payment of the issue fee	Requires filing a petition; no right to have IDS considered

Practical advice: submit the IDS concurrently with the application (within Window 1) — no fee, no statement required, and any newly discovered references can still be added in Window 2 at little or no cost.

Consequences of Non-Disclosure: Inequitable Conduct

The risk of failing to submit an IDS is extreme — it is sometimes called the "nuclear weapon" of patent law: if a court finds that the applicant intentionally withheld material information, the entire patent is rendered unenforceable. Once found, this cannot be remedied by reissue or amendment.

The current legal standard comes from Therasense, Inc. v. Becton, Dickinson and Co. (Fed. Cir. 2011, en banc):

But-for materiality: the withheld information would have changed the outcome — i.e., the examiner would not have allowed the relevant claims had the information been known
Specific intent to deceive: must be proven independently; intent cannot be inferred from materiality alone

For applications claiming foreign priority, practitioners must systematically gather all prior art references cited during prosecution of the CN/EP/JP counterpart applications — this is the most common IDS failure point for non-US firms.

IV. Entity Status and Fee Discounts

USPTO official fees are tiered by applicant entity status, with substantial differences between levels:

Three-Tier Classification

Entity Type	Fee Discount	Key Eligibility Criteria
Micro Entity	80% discount	Qualifies as small entity + inventor has not been named on more than 4 prior US applications + applicant's gross income does not exceed $234,420 (2025 threshold)
Small Entity	60% discount	Individual inventors, businesses with fewer than 500 employees (including affiliates), non-profit organizations; and the invention has not been assigned or licensed to a non-small-entity
Large Entity	No discount	All applicants not qualifying for the above

Fee Comparison (2025)

Basic utility patent application fees (including search and examination fees):

Fee Item	Large Entity	Small Entity	Micro Entity
Basic filing fee	$1,600	$640	$320
20-year full cycle (filing + issue + maintenance)	~$17,800	~$7,100	~$3,600

Timing of Declaration and Risk

Entity status is declared at first payment. If status subsequently changes (e.g., the company grows beyond 500 employees, or the invention is licensed to a large entity), the declaration must be updated promptly. USPTO has intensified scrutiny of entity status fraud in recent years — fraudulent entity status declarations can invalidate a patent.

A particular caution: startups may expand rapidly after a funding round. Practitioners should proactively confirm client entity status before each maintenance fee payment.

V. Strategic Choice: Provisional vs. Non-Provisional Application

The provisional application is unique to US patent law and has no counterpart in Chinese, European, or Japanese practice. Understanding its strategic value is especially important for practitioners serving startup clients.

Provisional vs. Non-Provisional: Core Comparison

Aspect	Provisional Application	Non-Provisional Application
Purpose	Establish a priority date; obtain "Patent Pending" status	Formal application; can mature into a granted patent
Examination	Not examined; automatically expires	Substantive examination by USPTO
Claims	Not required (draft claims recommended)	Mandatory
Format requirements	Relaxed; PDF acceptable	Strict; DOCX required
Fee (small entity)	$130	$640 (basic fee)
Validity	12 months; no extension available	Examined until grant or abandonment

Strategic Value of the Provisional Application

For startups, the core value of a provisional application is: lock in a priority date at low cost. Before the product is mature or the business model validated, a provisional can be filed quickly using R&D reports or technical documents, securing a 12-month window to refine the invention, attract investment, and validate the market — then a full non-provisional application can be filed within those 12 months.

Key Considerations When Converting Provisional to Non-Provisional

Month 0:    File provisional application (invention description + sketches)
Months 1–9: Add examples and experimental data, refine drawings, conduct prior art search
Months 9–11: Draft non-provisional application (claims + full specification + formal drawings + IDS + ADS)
Before Month 12: File non-provisional application; claim priority in the ADS

Two high-risk points:

First, the 12-month deadline is absolute — no extension. Once it expires, the provisional automatically lapses, the priority date is lost, and no protection based on the provisional can be restored.

Second, new matter risk. The claims in the non-provisional must be supported by the disclosure in the provisional; otherwise those claims cannot benefit from the provisional's priority date. Gaps or vague language in the provisional will directly limit the scope of claims available in the non-provisional.

Practical advice: begin drafting the non-provisional at the 9-month mark, leaving 3 months of buffer for technical details and review.

VI. Key Differences Between US and Chinese Practice

The table below summarizes the most common knowledge gaps encountered by Chinese patent practitioners entering the US market:

Aspect	Chinese Practice	US Practice	Risk Level
IDS system	No equivalent	Statutory duty under 37 CFR 1.56; violation renders patent unenforceable	Critical
Claim format	Two-part "characterized in that" structure	comprising / consisting of; no two-part format	High
Specification section order	Technical field / Background / Summary / Drawings description / Embodiments	9-section order under 37 CFR 1.77(b); ALL CAPS headings	High
Abstract word limit	≤300 Chinese characters	≤150 words	Medium
Provisional application	No equivalent	12-month placeholder; essential for startups	Medium
Entity status discounts	None	Three-tier; fraudulent declaration invalidates patent	High
Document format	PDF / XML	DOCX mandatory since 2024; surcharge otherwise	Medium
Inventor declaration	No equivalent	Required (may be deferred to issue fee payment)	Medium
CRM claims	Not applicable	Standard third independent claim type for software patents	Medium
Specification amendment	Strictly limited to correcting obvious errors	New matter restrictions apply, but claims may be freely amended during prosecution	Medium
Excess claim fee threshold	Surcharge beyond 10 claims	Surcharge beyond 20 total claims or 3 independent claims	Low

VII. Common Practice Pitfalls and How to Avoid Them

Pitfall 1: Incomplete IDS Due to Missing Counterpart References

When handling a US application claiming CN priority, practitioners must proactively request and compile all references cited during prosecution of the Chinese counterpart application and submit them to USPTO via PTO/SB/08. This is the most common IDS failure by non-US firms — and the consequences are irreversible.

Pitfall 2: Incorrect Specification Section Heading Format

37 CFR 1.77 requires section headings to be in ALL CAPS — no bold, no underline, no italics. Many practitioners are accustomed to bolded headings in Chinese applications and must adjust their habits for US format. In addition, the claims and abstract must each begin on a new page; they cannot run immediately after the specification body.

Pitfall 3: Missing Inventor Oath or Declaration

The Inventor's Oath or Declaration (37 CFR 1.63) is a statutory document. While AIA permits deferral until payment of the issue fee, an omission renders the application incomplete and can affect establishment of the filing date. Each inventor must sign individually — in a multi-inventor application, a missing signature from any one inventor creates a problem.

Pitfall 4: Ignoring the DOCX Submission Requirement

Since 2024, applications with specifications submitted in PDF are subject to a surcharge of $172 (small entity) to $430 (large entity) per application. While this does not affect the filing date, it is an entirely avoidable cost.

Pitfall 5: Misqualification for Micro Entity Status

Micro entity eligibility is strictly defined, particularly the restriction that "the inventor has not been named on more than 4 prior US applications." This condition is easily triggered by prolific inventors. An incorrect micro entity declaration can expose the patent to invalidity challenges in subsequent proceedings.

VIII. AI Tools in USPTO Practice: Capabilities and Limits

In recent years, AI patent drafting tools (Solve Intelligence, DeepIP, Patlytics, etc.) have gained rapid adoption in the US market, with reports of 20–50% time savings in drafting. For US practice, it is important to have a clear-eyed view of both the value and the limitations of these tools.

Where AI tools excel:

Generating draft claims in a Claims-First workflow
Producing specification frameworks following the 37 CFR 1.77(b) section order
Managing abstract word count (≤150 words)
Generating DOCX-format output to avoid non-DOCX surcharges
Auto-generating PTO/SB/08 IDS forms from known references

Where human judgment remains indispensable:

Completeness review of IDS — AI can assist with searching, but the final determination of which references are "material" requires a practitioner's professional judgment
Entity status determination — requires understanding the client's specific legal structure, affiliates, and licensing arrangements
Therasense compliance assessment — whether intentional concealment risk exists is a legal judgment
Novelty and inventive step analysis of claims — requires genuine understanding of the technology and the boundaries of the prior art

The core of US patent practice — the IDS Duty of Candor — is a dynamic obligation that runs throughout the entire prosecution process. It cannot be discharged as a one-time formatting exercise at filing. Practitioners must continuously apply professional judgment here; AI tools can only provide efficiency gains at the document generation layer.

Much of the complexity of US patent practice stems from its claim-centric legal system and its distinctive culture of candor obligations. Mastering the formal requirements of 37 CFR 1.77 is only the entry point — the real core of practice is building IDS compliance awareness and deeply internalizing the Claims-First methodology. Patent firms preparing to enter the US market are advised to systematically train all practitioners on the legal risks of the IDS system before formally accepting US applications, and to establish standardized IDS tracking and update workflows.

Complete Guide to US Patent Drafting: From 37 CFR 1.77 to IDS Compliance